European Stocks Higher On U.S. Vaccine Approval, Extended Brexit Talks
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks traded higher on Monday, despite mixed Asian cues, following news that the United States will start Covid-19 vaccinations today after the drug regulators approved the Pfizer- BioNTech's COVID-19 vaccine.
The U.S. Centers for Disease Control and Prevention or CDC, gave the approval for Pfizer- BioNTech's COVID-19 vaccine, following the Emergency Use Authorization or EUA issued by the U.S. Food and Drug Administration. Pfizer commenced first shipments of the vaccine to distribution centers across the country.
Investor sentiment also reflected hopes for a post-Brexit trade deal after the European union and the U.K. extended negotiations beyond the Sunday deadline. U.K Prime Minister Boris Johnson and EU Commission President Ursula von der Leyen agreed to 'go the extra mile' in coming days to reach a deal.